Latest news

Filter by
Date
Nov 30, 2022 11:38 AM

CSL Florey Next Generation Award shortlist recognises a risi...

An early career researcher at the Garvan Institute has been selected by the Australian Institute of Policy and Science as one of three finalists for a prestigious biennial award.

MEDIA RELEASE: Nov 29, 2022 09:01 AM

Rogue immune cells linked to leukaemia are a key driver of a...

Scientists have pinpointed rogue immune cells as a major contributor to autoimmune conditions like rheumatoid arthritis and aplastic anaemia.

MEDIA RELEASE: Nov 21, 2022 01:50 PM

Tumour matrix profiling gives clues to progression of some l...

Molecular profiles of the matrix around non-small cell lung cancers identifies which tumours become aggressive and require more targeted treatment.

Nov 18, 2022 12:47 PM

Accelerator Grant for pancreatic cancer researcher

PanKind Foundation supports new study to develop tailored therapy for pancreatic cancer.

Nov 18, 2022 11:29 AM

Garvan researcher announced as a Superstar of STEM

Dr Amanda Khoury will take part in an acclaimed national program, becoming a role model for the next generation of scientists.

MEDIA RELEASE: Nov 08, 2022 10:22 AM

DNA barcoding reveals cancer cells’ ability to evade the imm...

Using DNA barcodes to track cancer cells through time, Garvan scientists have shown that cells within a cancer have diverse abilities to escape immune system defences.

Nov 02, 2022 03:40 PM

Five-year funding for research on new pathways to boost chem...

Associate Professor Robert Weatheritt has been selected as a Viertel Senior Medical Research Fellow.

MEDIA RELEASE: Oct 31, 2022 01:39 PM

World-first gene therapy clinical trial for type 1 diabetes ...

A clinical trial to test how genetically engineered cells might restore insulin function and reduce the need for immunosuppression in patients with type 1 diabetes has been funded.

MEDIA RELEASE: Oct 20, 2022 12:47 PM

Clinical trial will test drug treatment for prevention of de...

A commonly used treatment for diabetes may hold the key to slowing cognitive decline to prevent dementia. This Phase 3 clinical trial is seeking participants.

MEDIA RELEASE: Oct 12, 2022 12:30 PM

Garvan researchers awarded five NHMRC Investigator Grants

The NHMRC has allocated $9 million to fund the critical research projects of five outstanding Garvan researchers.

MEDIA RELEASE: Oct 11, 2022 09:07 AM

Patterns of underlying health issues linked to poorer outcom...

Considering underlying health issues more comprehensively when a patient has a fracture could better identify those at higher risk of poor health outcomes.

MEDIA RELEASE: Oct 04, 2022 09:09 AM

Higher body temperature alters key protein in autoinflammato...

Groundbreaking research offers insights into understanding the inflammatory disorder mevalonate kinase deficiency, and reveals new potential treatment approaches for this devastating disease.

MEDIA RELEASE: Oct 03, 2022 01:07 PM

New epigenetic markers for prostate cancer discovered

The discovery of a new biomarker for prostate cancer could lead to better diagnosis and treatment for men with the aggressive form of this disease.

MEDIA RELEASE: Sep 26, 2022 12:07 PM

More inclusive genomic resource for diverse Australian commu...

Populations not currently represented in genetic databases will now have inclusion, thanks to support from the Medical Research Future Fund.

Sep 26, 2022 12:02 PM

New genomic database to help boost Indigenous healthcare

New genomics resources to help Indigenous Australians find genetic diagnoses will be established thanks to support from the Medical Research Future Fund.

Aug 18, 2022 07:59 AM

Pancreatic cancer clinical trial to test new approach to tre...

A new trial will test whether ‘priming’ pancreatic cancer can make it more susceptible to chemotherapy.

MEDIA RELEASE: Aug 10, 2022 11:02 AM

Collagen a key player in breast cancer metastasis

The level of collagen type XII in breast tumours plays an important role in triggering the spread of cancer cells around the body.

Jul 27, 2022 08:21 AM

Garvan researchers selected as Eureka Prize finalists

Professor Sandra O’Toole and Kate Harvey are finalists in the 2022 ANSTO Eureka Prize for Innovative Use of Technology.

MEDIA RELEASE: Jul 26, 2022 07:22 PM

Genetic clues to age-related macular degeneration revealed

The discovery of molecular signatures of age-related macular degeneration will help with better diagnosis and treatment of this progressive eye disease.

Jul 13, 2022 09:11 AM

Dr Anna Cuomo recognised with EMBO fellowship

Dr Cuomo has been awarded a highly competitive, international two-year fellowship.

Jul 11, 2022 01:35 PM

Garvan celebrates Professor Chris Goodnow and his extensive ...

Professor Goodnow FAA FRS steps down from Executive Directorship for health reasons after four years at the helm but to continue as senior Faculty and head of Hope Research program.